IceCure Medical (ICCM) Depreciation & Amortization (CF) (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $69000.0 in Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 22.47% year-over-year to $69000.0 in Q1 2026; TTM through Mar 2026 was $275000.0, a 18.15% decrease from a year earlier, with the FY2025 full-year figure at $295000.0, down 11.14% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $69000.0, down from $71000.0 in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for ICCM reached as high as $89000.0 in Q1 2025 and fell as low as $52000.0 in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $74529.4 across 5 years, with a median of $79000.0 in 2023.
• Across the five-year window, Depreciation & Amortization (CF) surged 126.09% in 2022 and fell 24.39% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $74000.0 in 2022, then climbed by 12.16% to $83000.0 in 2023, then retreated by 1.2% to $82000.0 in 2024, then fell by 13.41% to $71000.0 in 2025, then declined by 2.82% to $69000.0 in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $69000.0 in Q1 2026, $71000.0 in Q4 2025, and $73000.0 in Q3 2025.